Neurosteroid Modulation in Stress-Related Disorders

Neurosteroids are steroidal molecules synthesised within the nervous system that exert rapid modulatory effects on neuronal excitability. They influence the activity of key inhibitory neurotransmitter receptors, notably γ­-aminobutyric acid type A (GABAA) receptors, and thereby regulate the hypothalamic–pituitary–adrenal (HPA) axis, the principal neuroendocrine circuit governing stress responses. Dysregulation of neurosteroid levels—such as the progesterone‐derived allopregnanolone—and consequent disturbances in GABAergic inhibition have been implicated in the pathophysiology of stress‐related disorders, including major depressive disorder (MDD), post-traumatic stress disorder (PTSD) and postpartum depression (PPD). Chronic stress attenuates endogenous neurosteroid synthesis, leading to HPA hyperactivity, heightened anxiety and impaired emotional resilience. Restoration or enhancement of neurosteroid signalling through exogenous administration or through agents that stimulate endogenous synthesis has demonstrated rapid alleviation of depressive and anxiety symptoms, re-establishment of HPA axis homeostasis and improved fear extinction. These advances carry global significance as they open new avenues for intervention in treatment-resistant conditions and perinatal mood disorders. Novel neurosteroid modulators offer fast-acting profiles distinct from conventional antidepressants, and ongoing research seeks to optimise oral formulations, elucidate anti-inflammatory actions and integrate neurosteroid biomarkers into personalised treatment strategies.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Neurosteroid Modulation in Stress-Related Disorders publication trend

The graph below shows the total number of articles in neurosteroid modulation in stress-related disorders across all publications each year (not limited to Nature Index journals).

Technical terms

Neurosteroid: A steroid molecule synthesised in the brain that modulates neuronal receptor function.

GABAergic: Pertaining to the inhibitory neurotransmitter γ-aminobutyric acid and its signalling pathways.

HPA axis: The neuroendocrine system involving the hypothalamus, pituitary gland and adrenal cortex, central to stress response regulation.

Allopregnanolone: A progesterone-derived neurosteroid that acts as a positive allosteric modulator of GABAA receptors.

Positive allosteric modulator: A compound that binds to a receptor at a site distinct from the agonist binding site to enhance receptor response.

References

1. Efficacy and safety of zuranolone in major depressive disorder: a meta-analysis of factor effect and dose-response analyses. EClinicalMedicine (2023).
2. Novel neurosteroid therapeutics for post-partum depression: perspectives on clinical trials, program development, active research, and future directions. Neuropsychopharmacology (2023).
3. Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder. Translational Psychiatry (2023).